Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114213411B details a novel Ripretinib synthesis route offering high purity and reduced toxicity, ensuring cost reduction in pharmaceutical manufacturing and supply chain stability.
Patent CN103450183A reveals a safer, one-pot solifenacin succinate synthesis avoiding sodium hydride. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel synthetic route for Evogliptin intermediates ensures high purity and scalable production for global pharmaceutical supply chains.
Novel palladium-catalyzed route for tetraenyl acetate reduces corrosion and enhances purity for steroid drug manufacturing supply chains.
Patent CN101497589B details a scalable synthesis for 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid, offering cost-effective manufacturing solutions.
Novel chelating agent replaces pyridine in clindamycin phosphate synthesis reducing pollution and enhancing purity for reliable pharmaceutical intermediates supplier operations.
Patent CN115678953A details a green enzymatic route for high-purity cholesterol, offering superior isomer control and safety for reliable pharmaceutical intermediate supply chains.
Patent CN116003439A reveals a high-yield refining method for ceftiofur hydrochloride, ensuring >99.7% purity and reduced manufacturing costs for veterinary pharmaceutical supply chains.
Novel ethanol-based route for Tegaserod Maleate. Enhances purity, reduces toxicity, and optimizes cost for API manufacturing.
Novel chiral Brønsted acid catalysis method for unnatural serine. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN114437169B reveals a green, solvent-free ball milling method for synthesizing high-purity drospirenone intermediates, offering significant cost and supply chain advantages.
Patent CN102093166B details a scalable asymmetric synthesis of (S)-trans-1-yn-4-en-eicosan-3-ol with >97% ee, offering a reliable alternative to natural extraction for pharmaceutical applications.
Patent CN103073483A reveals a safe, high-yield route for Mepivacaine using formic acid. Discover cost-effective manufacturing and reliable supply chain solutions.
Advanced synthesis of Peramivir via CN102372657B. Replaces expensive PtO2 and toxic HgCl2. Cost-effective, scalable API intermediate manufacturing solution.
Patent CN113354534B details a green synthesis route for D-FMC. This method ensures high purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Novel convergent route for bortezomib manufacturing ensures over 99.8 percent purity. Reduces racemization risks and simplifies hydrolysis for reliable supply chain partners.
Patent CN116159594A introduces a metal-free photocatalytic route for quinazolinones. This green method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN115925682B reveals a safer Topiroxostat route avoiding toxic cyanides. Discover cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN109651202A enables safe carbamate synthesis using CO2. Reduces toxicity risks and simplifies supply chain for pharmaceutical intermediates.
Novel three-step nucleophilic substitution route for Adefovir using ethylene oxide and magnesium tert-butoxide, offering high purity and industrial scalability.